Lana Pine

A new study study showcased the accuracy of an algorithm in identifying pregnant patients with inherited bleeding disorders, unlocking new possibilities for precision healthcare.

Although gout was not associated with hearing loss, hyperuricemia was significantly linked to impairment.

Women with psoriatic arthritis reported higher mean pain and worse mean patient global assessment when compared with men.

Women with gout were more likely to exhibit chronic kidney disease, heart failure, dementia, diabetes mellites, and obesity, among others, when compared with men.

Patients who exhibited unrestful sleep had significantly reduced health-related quality of life and significantly more depressive symptoms.

Patients in the land- and water-based exercise intervention groups demonstrated greater improvements in fatigue when compared with controls.

Adverse events were significantly more frequently reported by pregnant patients when compared with non-pregnant patients. However, no differences were observed when comparing pregnant patients with autoimmune disease and healthy controls.

Compared with those without SLE, those with SLE had a higher risk of fetal morbidity and mothers were almost 4 times as likely to require a blood transfusion or develop a cerebrovascular disorder.

At month 3, patients treated with tofacitinib achieved higher rates of ACR20/50, MDA, and PASI75 in both sexes when compared with the placebo. However, female patients were less likely to achieve MDA when compared with males.

An analysis of perimenopausal women with rheumatoid arthritis indicated that patients receiving exogenous sex hormones more frequently achieved SDAI- and CDAI-defined remission.